The deputy first minister has said she engages "with the office of president" rather than his "particular personal views".
The pharmaceutical firm has followed several companies which have dropped diversity goals amid pressure from President Donald ...
For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation ...
London open The FTSE 100 is expected to open 69 points lower on Friday, having closed up 0.28% on Thursday at 8,756.21.
Almost half of councils in England risk falling into bankruptcy without action to address a £4.6bn deficit amassed under a ...
GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...
Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...
President Donald Trump has issued a series of executive ... proposed increasing the annual salary of its Chief Executive Emma Walmsley to as much as 21.6 million pounds , from 10.6 million pounds ...
Dame Emma Walmsley, chief executive of drugs giant GSK, received £10.6million in salary and bonuses in 2024 and under a new pay structure could receive as much as £21.6million for this year.
British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's opposition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results